HOMEVULNERABILITIESCVE-2014-5406
HIGH

CVE-2014-5406

CWE-345Published: July 6, 2015· Updated: Jun 17, 2026

7.6
CVSS v3.1

Official Description

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

NVD Source

Technical Analysis

CVE-2014-5406 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityC
IntegrityC
AvailabilityC
AV:N/AC:H/Au:N/C:C/I:C/A:C

Affected Vendors & Products

hospira3 product(s)
lifecare pcainfusion firmwarelifecare pca3lifecare pca5
Source: NVD CPE · 3 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (7)

Quick Facts

CVE IDCVE-2014-5406
CVSS Score7.6 / 10
SeverityHIGH
WeaknessCWE-345
CISA KEVNo
Affected1 vendor(s)
PublishedJul 6, 2015

Related CVEs (CWE-345)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2014-5406 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.